Parvovirus B19 Passive Transmission by Transfusion of Intercept® Blood System-Treated Platelet Concentrate
Authors:
Open Access
- 3 May 2016
- journal article
- case report
- Published by S. Karger AG in Transfusion Medicine and Hemotherapy
- Vol. 43 (3) , 198-202
Abstract
Background: Pathogen reduction methods for blood components are effective for a large number of viruses though less against small, non-enveloped viruses such as Parvovirus B19 (B19V). This article describes the passive transmission by transfusion of two B19V-contaminated pooled platelet concentrates (PCs) which were treated with the Intercept® blood pathogen reduction system. Case Reports: Two transfusion cases of B19V-contaminated Intercept-treated pooled PCs were described. Due to the analysis delay, the PCs were already transfused. The viral content of each donation was 4.87 × 1010 IU/ml in case 1and 1.46 × 108 IU/ml in case 2. B19V (52 IU/ml) was detected in the recipient of the case 1 PC, whereas no virus could be detected in the case 2 PC recipient. A B19V IgM response and a transient boost of the underlying B19V IgG immune status and was observed in recipient 1. Recipient of the case 2 PC remained B19V IgG- and IgM-negative. B19V DNA sequence and phylogenetic analysis revealed a 100% homology between donor and recipient. Conclusion: This report describes passive B19V transmission by a PC with very high B19 viral load which elicited a transient boost of the B19V immunity, but not by a PC with a lower B19V content, suggesting that there is a B19 viral load threshold value at which B19V inactivation is exceeded.Keywords
This publication has 26 references indexed in Scilit:
- Symptomatic parvovirus B19 infection caused by blood component transfusionTransfusion, 2011
- Recipients potentially infected with parvovirus B19 by red blood cell productsTransfusion, 2011
- Pathogen Inactivation of Platelet and Plasma Blood Components for Transfusion Using the INTERCEPT Blood SystemTMTransfusion Medicine and Hemotherapy, 2011
- Parvovirus B19 infection transmitted by transfusion of red blood cells confirmed by molecular analysis of linked donor and recipient samplesTransfusion, 2010
- A linked donor-recipient study to evaluate parvovirus B19 transmission by blood component transfusionBlood, 2009
- Seroprevalence of parvovirus B19 in the German populationEpidemiology and Infection, 2008
- Clustal W and Clustal X version 2.0Bioinformatics, 2007
- Human erythrovirus B19 and blood transfusion – an updateTransfusion Medicine, 2007
- The Immune Response to Parvovirus B19 Exposure in Previously Seronegative and Seropositive IndividualsThe Journal of Infectious Diseases, 2006
- Parvovirus B19 transmission by a high‐purity factor VIII concentrateTransfusion, 2005